Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Why Rapid Tests Fail to Gain Traction
Technology and innovation Insights Infectious Disease

Why Rapid Tests Fail to Gain Traction

Researchers identify key factors affecting the adoption and long-term use of rapid diagnostic tests across sub-Saharan Africa

06/24/2026 News 2 min read
  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Top Institutions
  • Topic Commentary

Share

Clinical Scorecard: Why Rapid Tests Fail to Gain Traction

At a Glance

CategoryDetail
ConditionRapid Diagnostic Tests (RDTs)
Key MechanismsFactors influencing the adoption and long-term use of RDTs for febrile illnesses.
Target PopulationPatients in sub-Saharan Africa with febrile illnesses.
Care SettingHealthcare organizations implementing RDTs.

Key Highlights

  • Identified 436 implementation factors affecting RDT adoption.
  • Common barriers include stockouts, poor integration, and insufficient training.
  • Facilitators include simple test design and reliable supply chains.
  • Organizational factors are critical for sustained use of RDTs.
  • Single-disease testing programs may lead to diagnostic uncertainty.

Guideline-Based Recommendations

Diagnosis

  • Integrate RDTs into clinical workflows to inform decision-making.

Management

  • Address multiple potential causes of fever rather than relying on single-disease testing.

Monitoring & Follow-up

  • Ensure regular training and supervision for healthcare workers.

Risks

  • Inappropriate antibiotic prescribing due to diagnostic uncertainty.

Patient & Prescribing Data

Patients with febrile illnesses in sub-Saharan Africa.

Negative RDT results may leave clinicians with limited diagnostic options.

Clinical Best Practices

  • Focus on workflow integration and supply management.
  • Maintain reliable electricity supplies and equipment.
  • Implement regular training for healthcare workers.

Related Resources & Content

  • Nature Communications

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.